Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis

Documenti analoghi

• The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis
  di: Dian‐yu Zheng, et al.
  Pubblicazione: (2024)
• Systematic review and meta‐analysis: Impact of depression on prognosis in inflammatory bowel disease
  di: Yuejin Ji, et al.
  Pubblicazione: (2024)
• Adverse events in endoscopic ultrasound‐guided choledochoduodenostomy with lumen‐apposing metal stents: A systematic review and meta‐analysis
  di: Jia‐Su Li, et al.
  Pubblicazione: (2024)
• Prevalence and etiologies of non‐responsive celiac disease: A systematic review and meta‐analysis
  di: Nishant Aggarwal, et al.
  Pubblicazione: (2024)
• Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease
  di: Alexis Bejcek, et al.
  Pubblicazione: (2024)